# S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

> **NCT01498289** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 213 (actual)

## Conditions studied

- Adenocarcinoma of the Gastroesophageal Junction
- Esophageal Cancer
- Gastric Cancer

## Interventions

- **DRUG:** FOLFOX regimen
- **DRUG:** docetaxel
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT01498289
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2018-03
- **Final completion:** 2019-09-19
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2019-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498289, "S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01498289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*